Procedure

Ovarian ECM in Navi Mumbai | Stem Rx IVF

Explore ovarian extracellular matrix (ECM) research at Stem Rx IVF, Navi Mumbai. An emerging regenerative approach for ovarian tissue support. Consult Dr. Pallavi Lale.

Book a Consultation

Our team will get back to you within 2 hours

What is Ovarian Extracellular Matrix (ECM) and is it available at Stem Rx IVF?

The ovarian extracellular matrix (ECM) is the structural scaffold of proteins and molecules that surrounds and supports ovarian cells. At Stem Rx IVF in Navi Mumbai, ovarian ECM is explored as an emerging regenerative medicine approach aimed at supporting ovarian tissue structure and reproductive health. Its clinical applications remain under active scientific investigation.

Note: Ovarian ECM-based approaches are investigational. They are not a replacement for established fertility treatments such as IVF. Suitability is assessed individually by a qualified specialist.

The ovarian ECM provides a three-dimensional environment that regulates follicle development, hormone signalling, and cell survival. Disruption of this matrix — due to ageing, surgery, autoimmune conditions, or chemotherapy — is associated with reduced ovarian reserve and impaired follicular function. Researchers are investigating whether restoring or supplementing this matrix environment can support ovarian tissue health in select patients.

At Stem Rx IVF, this area of Fertility and Reproductive Medicine is approached with scientific rigour, and patients are counselled transparently about the current state of evidence before any intervention is considered.

Who may be considered for Ovarian ECM evaluation at Stem Rx IVF?

Ovarian ECM research is most relevant to patients whose ovarian function has been affected by structural or cellular changes. The following groups may be candidates for evaluation and discussion with a specialist:

  • Premature Ovarian Insufficiency (POI): Women under 40 experiencing reduced or absent ovarian function before natural menopause.
  • Low ovarian reserve: Patients with low anti-Müllerian hormone (AMH) levels or low antral follicle count (AFC) on ultrasound.
  • Post-surgical ovarian damage: Women who have undergone ovarian cystectomy or other procedures affecting ovarian tissue.
  • Chemotherapy or radiotherapy-related ovarian damage: Patients whose ovarian function has been affected by cancer treatment.
  • Repeated IVF failure with poor ovarian response: Women who have had multiple stimulation cycles with inadequate follicular response despite optimised protocols.
  • Autoimmune-related ovarian dysfunction: Cases where immune-mediated processes have disrupted normal ovarian architecture.

Warning: Ovarian ECM approaches are investigational and not approved as standard clinical treatment in India. Eligibility must be assessed by a qualified gynaecologist or reproductive medicine specialist. Do not pursue any procedure without a formal medical consultation.

Suitability is determined after a thorough clinical assessment including hormonal profiling, pelvic ultrasound, and review of reproductive history. Use the booking form on this page or contact the team to arrange a consultation.

How is Ovarian ECM explored as a treatment approach at Stem Rx IVF?

The clinical pathway for ovarian ECM evaluation at Stem Rx IVF follows a structured, evidence-informed process. Because this is an investigational area, each step prioritises patient safety and informed consent.

  1. Initial consultation and history review: Dr. Pallavi Lale (MBBS, MD – Obstetrics and Gynaecology) reviews the patient's reproductive history, prior treatments, and current ovarian function markers.
  2. Diagnostic workup: Baseline investigations including serum AMH, FSH, LH, oestradiol, antral follicle count (AFC) via transvaginal ultrasound, and relevant autoimmune or genetic screening where indicated.
  3. Multidisciplinary review: Findings are reviewed in the context of current scientific literature on ovarian ECM. The clinical team discusses whether an ECM-based investigational approach is appropriate for the individual patient.
  4. Informed consent process: The patient receives a detailed explanation of the investigational nature of the procedure, available evidence, potential benefits, known risks, and alternative established treatments (including IVF).
  5. Procedure planning: If the patient proceeds, a personalised protocol is developed. ECM-based approaches may involve the use of decellularised ovarian scaffolds or ECM-derived biological materials, depending on the specific technique under investigation.
  6. Intervention: The procedure is performed under appropriate clinical conditions by the specialist team. Specific technique details are discussed with the patient at consultation, as approaches vary by case.
  7. Post-procedure monitoring: Hormonal and ultrasound follow-up is scheduled to assess ovarian response. Outcomes are documented as part of ongoing clinical evaluation.

For details on the specific techniques available and whether you are a candidate, use the booking form on this page or call +91 19152215415.

What are the different Ovarian ECM-based approaches being investigated?

Several ovarian ECM-related techniques are currently under scientific investigation globally. The table below summarises the main approaches, their proposed mechanisms, and their current evidence status. Not all approaches may be available or appropriate at every centre — discuss with your specialist.

ApproachProposed MechanismEvidence StatusInvasiveness
Decellularised Ovarian ScaffoldRemoves cells from donor ovarian tissue, leaving the ECM scaffold to support re-seeding with patient's own cellsPreclinical and early-phase researchSurgical
ECM-Derived Hydrogels / InjectablesBioactive ECM components delivered locally to support the ovarian microenvironmentEarly investigationalMinimally invasive
Platelet-Rich Plasma (PRP) with ECM SupportGrowth factors from PRP used alongside ECM components to promote tissue repair signallingLimited clinical studies; under investigationMinimally invasive
Exosome-Mediated ECM ModulationExtracellular vesicles used to deliver signals that may influence ECM remodelling in ovarian tissuePreclinical; emergingMinimally invasive

Stem Rx IVF also offers related regenerative approaches including exosome therapy and mitochondrial therapy, which may be considered alongside or as alternatives to ECM-based interventions depending on clinical assessment.

What does recovery look like after an Ovarian ECM procedure?

Recovery varies depending on the specific technique used. The following milestones apply to minimally invasive ECM-related approaches. Surgical approaches involving ovarian tissue manipulation will have a longer recovery timeline, discussed in detail at consultation.

  1. Immediately after the procedure (Day 0–1): The patient is monitored for any immediate adverse reactions. Minimally invasive approaches typically allow same-day discharge. Mild pelvic discomfort may be present.
  2. First week (Days 2–7): Rest is advised. Strenuous physical activity, sexual intercourse, and heavy lifting should be avoided. Any unusual pain, fever, or bleeding should be reported promptly.
  3. Hormonal follow-up (Week 2–4): Blood tests to assess AMH, FSH, and oestradiol levels are scheduled. These provide early indicators of ovarian response, though changes may take longer to manifest.
  4. Ultrasound assessment (Week 4–6): Transvaginal ultrasound to evaluate antral follicle count and ovarian morphology.
  5. Ongoing monitoring (Month 2–6): Serial hormonal and imaging assessments continue. The clinical team reviews whether any further intervention or transition to an established fertility treatment such as IVF is appropriate.
  6. Long-term review: Outcomes are assessed over a longer period. Patients are counselled that ovarian ECM approaches are investigational and that response cannot be predicted or guaranteed.

Tip: Keep all follow-up appointments. Early hormonal monitoring is essential to assess whether the ovarian environment is responding and to guide next steps in your fertility plan.

What are the risks and limitations of Ovarian ECM approaches?

As with any medical intervention — and particularly with investigational procedures — there are risks and important limitations that patients must understand before proceeding. The following apply to ovarian ECM-based approaches:

  • Unproven clinical efficacy: Ovarian ECM approaches have not yet been validated in large-scale randomised controlled trials. Improvement in ovarian reserve, egg quality, or pregnancy rates cannot be guaranteed.
  • Procedural risks: Minimally invasive approaches carry risks including infection, bleeding, and injury to adjacent structures. Surgical approaches carry additional anaesthetic and operative risks.
  • Immune or allergic reaction: Use of biological materials (including donor-derived ECM scaffolds) carries a risk of immune response, even after decellularisation.
  • No guarantee of fertility outcome: Even if ovarian tissue structure is supported, this does not ensure ovulation, egg retrieval success, or pregnancy.
  • Regulatory status in India: ECM-based regenerative therapies for ovarian dysfunction are not currently approved as standard treatments by Indian regulatory authorities. Patients should be aware they are participating in an investigational pathway.
  • Delay of established treatment: Pursuing investigational approaches may delay access to proven fertility treatments. This risk must be weighed carefully, particularly in patients with diminishing ovarian reserve.
  • Psychological impact: Uncertainty around outcomes can be emotionally challenging. Counselling support is recommended alongside any investigational treatment pathway.

Warning: Do not pursue ovarian ECM procedures from unregulated providers. Always ensure any intervention is performed by a qualified specialist in a licensed clinical facility, with full informed consent documentation.

Which specialist leads Ovarian ECM consultations at Stem Rx IVF?

Ovarian ECM consultations at Stem Rx IVF in Navi Mumbai are led by a qualified reproductive medicine specialist with formal training in obstetrics and gynaecology.

DoctorQualificationsSpeciality
Dr. Pallavi LaleMBBS, MD – Obstetrics and GynaecologyFertility and Reproductive Medicine

Dr. Pallavi Lale evaluates each patient's ovarian health comprehensively before discussing whether an ECM-based investigational approach is appropriate. She also oversees related fertility interventions including endometrial rejuvenation for patients with concurrent uterine lining concerns.

To book a consultation with Dr. Pallavi Lale, use the booking form on this page or contact the clinic directly.

Book a consultation at Stem Rx IVF

Use the booking form on this page, or reach out directly:

Call: +91 19152215415

WhatsApp: +919152215433

FAQs

  • The ovarian extracellular matrix is the structural framework of proteins and molecules that supports ovarian cells, regulates follicle development, and maintains the ovarian microenvironment. When this matrix is damaged — by ageing, surgery, or disease — ovarian function can decline. Researchers are investigating whether restoring or supplementing the ECM can support ovarian tissue health in patients with reduced ovarian reserve or ovarian dysfunction.
  • No. Ovarian ECM-based approaches are currently investigational and are not approved as standard clinical treatments by Indian regulatory authorities. They are being studied in research settings globally. At Stem Rx IVF, patients are fully informed of the investigational status before any procedure is considered. Established treatments such as IVF remain the evidence-based standard of care for most fertility conditions.
  • Patients who may be considered for evaluation include those with premature ovarian insufficiency (POI), low AMH, post-surgical ovarian damage, chemotherapy-related ovarian dysfunction, or repeated poor response to IVF stimulation. Suitability is assessed individually by Dr. Pallavi Lale (MBBS, MD – Obstetrics and Gynaecology) after a full clinical workup including hormonal profiling and pelvic ultrasound. Use the booking form on this page to arrange an assessment.
  • No. Ovarian ECM approaches cannot guarantee pregnancy, restoration of ovarian reserve, or an increase in egg count. These are investigational techniques without large-scale clinical trial data confirming efficacy. Any provider claiming guaranteed outcomes from ECM-based therapy should be approached with caution. At Stem Rx IVF, all patients receive transparent counselling about realistic expectations before proceeding.
  • IVF is an established, evidence-based assisted reproductive technology that retrieves eggs, fertilises them in a laboratory, and transfers embryos to the uterus. Ovarian ECM approaches are investigational techniques aimed at supporting the ovarian tissue environment itself — potentially improving the conditions for follicle development before or alongside IVF. They are not a replacement for IVF and may be considered as a complementary investigational step in select cases.
  • Yes, many ovarian cysts can be removed laparoscopically, depending on size, type, and clinical findings. Laparoscopic cystectomy is a minimally invasive approach with shorter recovery compared to open surgery. Ovarian ECM research is relevant in this context because cystectomy can affect the surrounding ovarian tissue and ECM integrity. Patients concerned about ovarian reserve after cyst removal may benefit from a specialist consultation at Stem Rx IVF.
  • Stem Rx IVF is located at Ground Floor, Dr. Mahajan's Hospital and ITC, R-831, Thane–Belapur Road, Next to Shell Petrol Pump, TTC Industrial Area, Rabale, Navi Mumbai – 400708. To book a consultation regarding ovarian ECM or any fertility concern, use the booking form on this page, call +91 19152215415, or WhatsApp +919152215433.
  • Stem Rx IVF offers several regenerative and advanced fertility approaches alongside ovarian ECM research, including exosome therapy, mitochondrial therapy, and endometrial rejuvenation. These may be considered individually or in combination depending on the patient's clinical profile. All options are discussed during a formal consultation with Dr. Pallavi Lale (MBBS, MD – Obstetrics and Gynaecology).

Get Expert Guidance — Speak with a Specialist Today

Our specialists will reach out within 24 hours with personalised advice tailored to your needs.


Prefer to talk now? with our team directly.

Contact Us Today